Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 5
1996 5
1997 6
1998 7
1999 4
2000 6
2001 4
2002 7
2003 11
2004 8
2005 13
2006 16
2007 9
2008 12
2009 11
2010 9
2011 14
2012 14
2013 5
2014 13
2015 5
2016 10
2017 7
2018 12
2019 8
2020 13
2021 8
2022 10
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

228 results

Results by year

Filters applied: . Clear all
Page 1
Development of SGLT1 and SGLT2 inhibitors.
Rieg T, Vallon V. Rieg T, et al. Among authors: vallon v. Diabetologia. 2018 Oct;61(10):2079-2086. doi: 10.1007/s00125-018-4654-7. Epub 2018 Aug 22. Diabetologia. 2018. PMID: 30132033 Free PMC article. Review.
Metabolic Communication by SGLT2 Inhibition.
Billing AM, Kim YC, Gullaksen S, Schrage B, Raabe J, Hutzfeldt A, Demir F, Kovalenko E, Lassé M, Dugourd A, Fallegger R, Klampe B, Jaegers J, Li Q, Kravtsova O, Crespo-Masip M, Palermo A, Fenton RA, Hoxha E, Blankenberg S, Kirchhof P, Huber TB, Laugesen E, Zeller T, Chrysopoulou M, Saez-Rodriguez J, Magnussen C, Eschenhagen T, Staruschenko A, Siuzdak G, Poulsen PL, Schwab C, Cuello F, Vallon V, Rinschen MM. Billing AM, et al. Among authors: vallon v. Circulation. 2024 Mar 12;149(11):860-884. doi: 10.1161/CIRCULATIONAHA.123.065517. Epub 2023 Dec 28. Circulation. 2024. PMID: 38152989 Free PMC article.
SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function.
Suijk DLS, van Baar MJB, van Bommel EJM, Iqbal Z, Krebber MM, Vallon V, Touw D, Hoorn EJ, Nieuwdorp M, Kramer MMH, Joles JA, Bjornstad P, van Raalte DH. Suijk DLS, et al. Among authors: vallon v. Clin J Am Soc Nephrol. 2022 May;17(5):663-671. doi: 10.2215/CJN.11480821. Epub 2022 Mar 23. Clin J Am Soc Nephrol. 2022. PMID: 35322793 Free PMC article. Clinical Trial.
Renoprotective Effects of SGLT2 Inhibitors.
Vallon V. Vallon V. Heart Fail Clin. 2022 Oct;18(4):539-549. doi: 10.1016/j.hfc.2022.03.005. Heart Fail Clin. 2022. PMID: 36216484 Free PMC article. Review.
SGLT2 inhibition and kidney protection.
Nespoux J, Vallon V. Nespoux J, et al. Among authors: vallon v. Clin Sci (Lond). 2018 Jun 28;132(12):1329-1339. doi: 10.1042/CS20171298. Print 2018 Jun 29. Clin Sci (Lond). 2018. PMID: 29954951 Free PMC article. Review.
Micropuncturing the nephron.
Vallon V. Vallon V. Pflugers Arch. 2009 May;458(1):189-201. doi: 10.1007/s00424-008-0581-7. Epub 2008 Aug 28. Pflugers Arch. 2009. PMID: 18752000 Free PMC article. Review.
A special issue on glucose transporters in health and disease.
Koepsell H, Vallon V. Koepsell H, et al. Among authors: vallon v. Pflugers Arch. 2020 Sep;472(9):1107-1109. doi: 10.1007/s00424-020-02442-w. Epub 2020 Aug 11. Pflugers Arch. 2020. PMID: 32780191 Free PMC article. No abstract available.
228 results